Sources: CBC
The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months. 2021-07-16
Canadian Prime Minister Justin Trudeau announces that the country will double its order of the Pfizer-BioNTech vaccine from 20 million to 40 million doses. 2021-01-12
Vaccine developer Pfizer announces that lab studies have concluded that the joint Pfizer–BioNTech vaccine remains effective against mutation variants of the SARS-CoV-2 virus, including Variant of Concern 202012-01 and the 501.V2 variant. 2021-01-8
Spain receives its first shipment of the Pfizer-BioNTech vaccine tozinameran in Guadalajara, a day before the country begins its vaccination programme. 2020-12-26
Mexico begins vaccinations with the Pfizer-BioNTech vaccine. An intensive care unit nurse in Mexico City becomes the first person in the country to receive the vaccine. 2020-12-24
Qatar begins administering the Pfizer-BioNTech vaccine tozinameran to its citizens at designated health centers in the country. Those aged over 70, adults with chronic health conditions and healthcare personnel are to be prioritised for the vaccine. 2020-12-23
Singapore receives the Pfizer-BioNTech vaccine, becoming the first country in Asia to do so. 2020-12-21
Prime Minister Lee Hsien Loong says that Singapore has approved the Pfizer-BioNTech vaccine. The country expects to receive shipments of the vaccine by the end of the year and to vaccinate 5.7 million people for free by the third quarter of 2021. 2020-12-14
Pfizer and BioNTech announce that they have started shipping their vaccine from a Michigan facility to all 50 states. 2020-12-13
Prime Minister Justin Trudeau says that the country will receive 240,000 doses of Pfizer and BioNTech’s vaccine candidate by the end of the year. 2020-12-7